Following delivery of placenta, for routine management of
uterine atony, hemorrhage and subinvolution of the uterus. For control of
uterine hemorrhage in the second stage of labor following delivery of the anterior
DOSAGE AND ADMINISTRATION
Parenteral drug products should be inspected visually for
particulate matter and discoloration prior to administration.
1 mL, 0.2 mg, after delivery of the anterior shoulder,
after delivery of the placenta, or during the puerperium. May be repeated as
required, at intervals of 2-4 hours.
1 mL, 0.2 mg, administered slowly over a period of no
less than 60 seconds (See WARNINGS.)
One tablet, 0.2 mg, 3 or 4 times daily in the puerperium
for a maximum of 1 week.
White, round, biconvex compressed tablets debossed with
“n” on one side and “01” on the other side. Available in
bottles of 7, 12, 28 and 100 tablets.
Bottles of 7â¦..â¦â¦â¦â¦â¦â¦NDC 27437-050-19
Bottles of 12â¦...â¦â¦.â¦â¦â¦NDC 27437-050-57
Bottles of 28â¦â¦â¦â¦â¦â¦â¦NDC 27437-050-56
Bottles of 100â¦â¦â¦..â¦â¦â¦NDC 27437-050-01
Store And Dispense
Tablets: Store below 25°C (77°F); in tight,
Manufactured by: Novel Laboratories, Inc., Somerset, NJ
08873. Manufactured for: Lupin Pharma, Baltimore, MD 21202. Revised:.